menu search

TransCode Therapeutics Announces Pricing of $7 Million Public Offering

TransCode Therapeutics Announces Pricing of $7 Million Public Offering
BOSTON, June 06, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of its public offering of an aggregate of 2,000,000 shares of its common stock (or common stock equivalents), together with accompanying common stock warrants, […] The post TransCode Therapeutics Announces Pricing of $7 Million Public Offering appeared first on ForexTV... Read More
Posted: Jun 6 2023, 21:29
Author Name: forextv
Views: 110141

Search within

Pages Search Results: